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Adherence of neutrophils to hemodialysis membranes: Role of comple-
ment receptors. Complement activation occurs during hemodialysis
using cellulosic dialysis membranes with the consequent deposition of
C3 activation and degradation products on the membrane surface. To
determine if these complement fragments are functionally active, we
examined their capacity to mediate leukocyte adherence to cuprophan
membranes. Immunoblotting of proteins eluted from plasma-treated
cuprophan membranes confirmed the presence of both C3b and iC3b.
Incubation of cuprophan membranes with heparinized whole blood
resulted in adherence of leukocytes but not erythrocytes. Neutrophils
were the primary cell type bound, with monocytes comprising less than
5% of the adherent cells. Studies using indium-labeled neutrophils
demonstrated that the binding was plasma dependent and increased
with time up to two hours. Neutrophil binding was inhibited by
preincubation of the plasma-treated cuprophan membrane with anti-C3
or preincubation of neutrophils with an antibody directed against the a
chain of complement receptor type 3 (CR3). These observations indi-
cate that iC3b deposited on cuprophan membrane surface as a result of
complement activation mediates neutrophil adherence via interaction
with CR3. They also support the hypothesis that, in addition to the
anaphylatoxins released into the fluid phase, complement activation
products that remained membrane bound during hemodialysis also
stimulate pathophysiological responses.
Many of the untoward consequences of hemodialysis using
cellulosic membranes have been attributed to the anaphylatox-
ins C3a and C5a that are derived from activation of the
alternative pathway of complement (APC) [1—6]. As a result of
APC activation, however, other biologically active proteins are
also generated. One of these peptides, iC3b (a degradation
product of C3b), mediates cell adhesion through interaction
with a specific receptor [complement receptor type 3 (CR3)]
that is constitutively expressed by neutrophils and monocytes
[7]. Binding of iC3b to CR3 is a proinflammatory process since
it induces both degranulation and respiratory burst in neutro-
phils [8] as well as release of platelet activating factor by
monocytes [9]. We have previously demonstrated that during
hemodialysis, C3 activation and degradation products become
membrane bound [5, 6, 10]. Conceivably, these fragments could
contribute to some of the pathological sequelae associated with
hemodialysis by mediating binding of peripheral blood leuko-
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cytes and consequently stimulating proinflammatory responses
in the adherent cells. Accordingly, we have characterized the
cells that bind to cuprophan membrane and identified the ligand
and the receptor that mediate the adhesion.
Methods
Reagents
The following buffers and reagents were used: PBS, 10 mM
sodium phosphate, pH 7.4 containing 145 m of NaCl;
HBSS/A, Hank's balanced saline solution containing 0.5%
(wt/vol) human serum albumin (Albuminar®, Armour Pharma-
ceutical, Kankakee, Illinois, USA); Tris buffer, 20 ms'i Tris, pH
7.4; disodium ethylenediamine tetraacetate (EDTA, Sigma
Chemical Co., St. Louis, Missouri, USA); phenylmethylsulfo-
nyl fluoride (PMSF, Sigma Chemical); sodium heparin (Ly-
phoMed, Rosemont, Illinois, USA); hydroxylamine (NH2OH,
Sigma Chemical).
Blood collection
Approximately 100 ml of blood (collected in 2 U of heparin/
ml) was obtained from healthy volunteers who had not taken
medication within 72 hours of the phlebotomy. Part of the blood
was incubated with membrane discs for morphologic examina-
tion of cells; another part was used to prepare normal human
plasma (NHP); and another part was supplemented with 5.5
units of heparin/mI and used for the isolation of neutrophils.
Analysis of C3-related peptides and IgG bound to plasma-
treated cuprophan membrane
Cuprophan membrane sheets were gifts of Dr. U. Baurmeis-
ter and Dr. J. Vienken (Akzo, Wuppertal, Germany). These
sheets (total surface area = 85 cm2) were incubated at 37°C for
two hours with 5 ml of NHP. After washing three times with
PBS containing 10 mrt EDTA and 1 msi PMSF, membrane
associated proteins were eluted by incubation at 37°C with 5 ml
of 1 M NH2OH containing 10 mM EDTA and 1 mM PMSF, pH
10.5 [5, 6]. At this alkaline pH, NH2OH has previously been
shown to effectively dissociate both covalently and nonco-
valently bound C3 fragments from surfaces [5, 111. After two
hours of incubation, the eluate was dialyzed three times against
1 liter of Tris buffer at 4°C. The dialyzed sample was concen-
trated by lyophilization and resuspended in 180 d PBS. An
aliquot of the concentrate was analyzed by SDS-PAGE and
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immunoblotting [5, 61. The primary antibody used in the immu-
noblots was goat anti-human C3 (Atlantic Antibodies, Scarbor-
ough, Maine, USA), rabbit anti-human C3d (DAKO, Santa
Barbara, California, USA), or the F(ab)'2 fragment of goat
anti-human IgG (Cappel, West Chester, Pennsylvania, USA).
The secondary antibody was alkaline phosphatase conjugated
swine anti-goat IgG or goat anti-rabbit IgG (Tago, Burlingame,
California, USA).
Histologic examination of cuprophan membrane discs
exposed to whole blood in vitro
Isolated pieces of cuprophan membrane (surface area 1 cm2)
were washed with sterile PBS and incubated at 37°C with 1 ml
of whole blood (containing 2 U/mI of heparin) in a 20 ml
scintillation vial (Wheaton Scientific, Miliville, New Jersey,
USA). After two hours, the membranes were washed three
times with PBS. The membranes were then stained with either
Giemsa-Wright reagent for morphology or stained for the mono-
cyte marker esterase [12]. Staining for esterase was accom-
plished using a-naphthyl acetate as substrate according to the
procedure recommended by the manufacturer (a-naphthyl ace-
tate esterase, Sigma Diagnostics). Other cuprophan discs that
had been treated with heparinized blood were examined by
scanning electronmicroscopy (JSM-35, JEOL USA, Inc., Pea-
body, Massachusetts, USA). For comparison, cuprophan mem-
brane discs that had been incubated for two hours with isolated
neutrophils (infra vida) in HBSS/A in the absence of plasma and
isolated neutrophils that had not been exposed to cuprophan
membranes were also examined by scanning EM.
Neutrophil isolation and labeling
Neutrophils were isolated with dextran sedimentation, hypo-
tonic lysis of red cells and density gradient separation (Ficoll-
Paque5, Pharmacia LKB Biotechnology, Piscataway, New
Jersey) as previously described [13]. The cell preparations were
>95% pure as determined by microscopic examination of slides
stained with Wright's reagent and the cells were 99% viable as
determined by trypan blue exclusion. The isolated cells were
suspended in HBSS/A and then labeled with "indium oxine
(Amersham, Arlington Heights, Illinois, USA) using 0.2 sCi/l06
cells [131. The specific activities ranged from 3,000 to 7,000
cpm/105 cells. The labeled cells were resuspended to 5.6 X 106
cells/mi for use in the adherence experiments described below.
Binding studies using radiolabeled neutrophils
Neutrophil binding to cuprophan membranes were analyzed
using a custom designed apparatus made from Plexi-glass. The
device consisted of two separate plates. The bottom plate was
a solid piece (21 cm in length x 9.8 cm in width X 3.5 cm in
height). The top plate was the same size but contained 12
circular through and through holes (1.7 cm in diameter with a
surface area of 2.23 cm3) each surrounded by a rubber gasket.
Individual circular pieces of dialysis membrane (2.2 cm in
diameter) were placed on the bottom plate. The top plate was
positioned so that the holes were directly above the pieces of
membrane, and the plates were held tightly together by six
screws. The dialysis membranes therefore formed the bottom of
the wells in which reagents and radiolabeled cells were added in
incubation experiments described below. Only one side of the
membranes was exposed to the reagents and cells.
Time dependence of neutrophil adherence to cuprophan
membrane
Aliquots of 0.5 ml of HBSS/A containing 2.8 x 106 radiola-
beled neutrophils and aliquots of 0.5 ml of heparinized NHP
were added to individual pieces of cuprophan membrane in the
wells of the apparatus described above. After incubation at
37°C for variable duration, the supernates were aspirated, and
the membranes were washed three times with 3 ml of PBS each.
Next, the apparatus was dismantled and the membrane was
washed once more by immersion in 30 ml of PBS. The mem-
branes were removed and the residual membrane-associated
radioactivity was quantified using a gamma counter. The num-
ber of adherent cells was determined based on the specific
activity of the labeled cells.
Effect of inhibition of complement activation on neutrophil
adherence to cuprophan membrane
Aliquots of 0.5 ml of HBSS/A containing 2.8 X 106 radiola-
beled neutrophils were mixed with aliquots of 0.5 ml of one of
the following reagents: (a) NHP; (b) NHP heated at 56°C for 30
minutes to inactivate complement; (c) NHP containing EDTA
(10 m final concentration). The samples were incubated with
pieces of cuprophan membrane in the wells of the binding
apparatus. After two hours, the supernates were removed and
the membranes were washed with PBS. The membrane-associ-
ated radioactivity was determined and the adherent cells were
quantified as described above.
Effect of anti-IgG or anti-C3 on neutrophil adherence to
cuprophan membrane
Cuprophan membranes were incubated with aliquots of 0.5
ml of either NHP or HBSS/A at 37°C in the binding apparatus.
After two hours, the membranes were washed twice with 3 ml
of PBS. Next, 200 d of PBS or PBS containing incremental
concentrations of the F(ab)'2 fragment of either goat anti-human
IgG (Cappel) or goat anti-human C3 (Cappel) were added to the
wells. After incubation at 37°C for 30 minutes, the supernates
were aspirated, and the membranes were washed twice with 3
ml of PBS. Next, an aliquot of I ml of HBSS/A containing 2.8
x 106 radiolabeled neutrophils was added to each well, and the
samples were incubated at 37°C. After two hours, the number of
adherent cells on the membrane was determined as described
above.
The percent inhibition at a particular concentration of anti-C3
was calculated as follows. Background binding was defined as
adherence of neutrophils to cuprophan membranes that had
been treated with HBSS/A instead of plasma. Total binding was
defined as adherence of neutrophils to membranes that had
been incubated with plasma and subsequently treated with PBS
or anti-C3, To define specific binding, background binding was
subtracted from the total binding. Percent inhibition by anti-C3
was then calculated using the following formula: [(specific
binding to PBS treated membranes) — (specific binding to
anti-C3 treated membranes)j/(specific binding to PBS treated
membranes) x 100%.
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Effect of anti-CRJ and anti-CR3 on neutrophil adherence to
cuprophan membrane
The role of complement receptors in mediating the adherence
of neutrophils to cuprophan membrane was examined using
antibodies directed against complement receptors type I (CR1)
and type 3 (CR3). Anti-CR! (3D9 [14]) was a gift from Dr. Eric
Brown (Washington University, St. Louis, Missouri, USA). A
monoclonal antibody directed against the a chain (CDI 1 b) of
CR3 [15], 60.1, was a gift from Dr. Patrick Beatty (Univ. of
Utah, Salt Lake City, Utah, USA). Both antibodies have been
shown to be blocking antibodies capable of inhibiting rosette
formation by erythrocytes coated with C3b [14] and iC3b [15],
respectively. Nonimmune monoclona! IgG was a gift of Dr.
Charles Parker (University of Utah).
Cuprophan membranes were incubated with 0.5 ml of either
NHP or HBSS/A in the binding apparatus. After two hours, the
membranes were washed with PBS as described above. At the
same time, radiolabeled neutrophils (2 x 106 cel!s/ml) sus-
pended in 250 d of HBSS/A were incubated at 37°C for 15
minutes with an equal volume of PBS or PBS containing various
concentrations of anti-CR3, anti-CR1, combination of anti-CR3
and anti-CR!, or nonimmune IgG. These treated cells were then
added to the wells of the binding apparatus that contained the
cuprophan membranes. After incubation at 37°C for two hours,
neutrophil binding was determined as described above. Inhibi-
tion by anti-CR! or anti-CR3 was calculated by using the same
formula as described above for anti-C3.
In a separate set of experiments, cuprophan membranes were
not preincubated with NHP. Instead, radiolabeled neutrophils
(2 x 106 cells/mI) suspended in 250 d of HBSS/A were
incubated at 37°C for 15 minutes with an equal volume of PBS
containing 25 pg of anti-CRI or anti-CR3, PBS containing 25 sg
of anti-CR! and 25 pg of anti-CR3, or 25 g of nonimmune IgG.
NHP was then added to these treated cells and the mixture was
incubated at 37°C with cuprophan membranes in the wells of the
binding apparatus. As a control for nonspecific binding, aliquots
of HBSS/A containing 2 x 106 radiolabeled neutrophils were
incubated with cuprophan membranes. After two hours, neu-
trophil adherence was determined as described above.
Results
Analysis of C3-re/ated peptides and IgG on plasma-treated
cuprophan membrane
Native C3 is a disulfide linked heterodimer comprised of a 113
kDa a chain and a 75 kDa f3 chain [16]. When C3 is activated by
C3 convertase, a 9 kDa fragment (C3a) is cleaved from the a
chain. The resultant C3b fragment is therefore comprised of a
104 kDa a chain (C3ba) and a 75 kDa /3 chain. C3b is inactivated
by the concert actions of two plasma proteins, factor H and
factor I. Cleavage by factor I removes a 3 kDa peptide from the
central region of C3ba, thereby generating iC3b. Thus, iC3b is
comprised of two a chain-derived fragments (a68 and a43) that
are disulfide linked to the /3 chain. The fragment iC3b can be
further degraded by factor I and factor H. In this case, a 41 kDa
fragment (C3dg) is cleaved from the a68 portion of iC3b,
thereby generating C3c. Thus, C3c is comprised of two a
chain-derived fragments (a27 and a43) that are disulfide linked
to the /3 chain.
After incubation of cuprophan disc with NHP for two hours,
the membrane associated proteins were eluted and analyzed by
SDS-PAGE and immunoblotting using polyclonal anti-C3 (Fig.
1A, lane d). Although some unactivated C3 could be identified
(as evident by the presence of a chain of native C3), most of the
C3-related peptides were in the form of activation and degra-
dation fragments. Conspicuously present was C3b (as evident
by C3ba). Inasmuch as it is the nidus for the formation of the
APC C3 convertase, the presence of C3b on the membrane
implied that APC activity was ongoing at that time point. As
evident by a68, iC3b was also present on the cuprophan
membrane (Fig. 1A, lane d). The observation that a43 is more
prominent than a68, however, suggests that C3c (which also
contains the a43 fragment) is also present. The presence of C3c
cannot be confirmed, since the antibody (polyclonal anti-C3)
does not recognize a27.
Immunoblotting of the eluate from NHP-treated cuprophan
membranes using anti-C3d and anti-IgG as primary antibodies,
in addition, revealed the presence of C3dg (Fig. lB, lane d) and
IgG (Fig. 1C, land c) respectively. These experiments demon-
strate that activation and degradation fragments of C3 as well as
IgG are present on cuprophan membranes following incubation
with plasma. Inasmuch as specific receptors for C3b, iC3b,
C3dg, and IgG are present on peripheral blood leukocytes [17,
18], it seems plausible that these peptides can mediate cell
adhesion to dialysis membranes.
Ident/ication of cells that bind to cuprophan membrane
following incubation with whole blood
Staining with Wright-Giemsa reagent of cuprophan mem-
branes that had been incubated with whole blood showed that
most of the adherent cells were polymorphonuclear (Fig. 2A).
Erythrocytes were nearly absent. Neutrophils were predomi-
nant but eosinophils and basophils were observed occasionally.
In five separate experiments using blood from five different
donors, neutrophils were found to comprise 93 1%of the cells
on the blood-treated membranes (mean number of cells counted
= 370). Inasmuch as the differential count showed that neutro-
phils comprised only 54 4% of the peripheral leukocytes from
the same donors, these results indicate that neutrophil binding
is selective. By using nonspecific esterase staining, 3.7 0.4%
of the cells on cuprophan membranes that had been incubated
with blood from these same five donors were identified as
monocytes (mean number of cells counted = 446) (Fig. 2B).
Examination by scanning EM showed that the neutrophils
adherent to cuprophan membranes had undergone extensive
morphological changes (Fig. 3A and 3B). The adherent cells
displayed elaborate lamellipods and microspikes extending in
all directions in the horizontal plane. Elongated uropods were
occasionally seen (Fig. 3A). In contrast, isolated neutrophils
that had been incubated with cuprophan membranes in the
absence of plasma resembled unactivated peripheral neutro-
phils in their spheroidal appearance [19] with the exception that
a few cytoplasmic projections attaching to the dialysis mem-
branes could be seen (Fig. 3C).
Time course of adherence of radiolabeled neutrophils to
cuprophan membranes
When radiolabeled isolated neutrophils were incubated with
cuprophan membranes in the presence of NHP, adherence was
observed after 15 minutes and increased in a linear fashion for
two hours (Fig. 4). Between two and four hours, a gradual
plateau phase was observed. Approximately 42% of the cells
that were offered bound to the membrane after four hours.
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Fig. 1. Immunoblots of C3-related peplides and IgG eluted from plasma treated cuprophan membrane. A. Immunoblot using anti-C3. Proteins
eluted from plasma treated cuprophan membranes were subjected to SDS-PAGE under reducing conditions. Subsequently, immunoblotting was
performed using polyclonal anti-C3 as primary antibody. Lane a, I zg of isolated C3 consisting of an a and /3 chain. Lane b, 1 jsg of C3 that had
been incubated with activated cobra venom factor (CVFBb) [61 showing the position of the a chain of C3b. Lane c, 4 d of plasma that had been
incubated with CVF. CVF induced activation of APC, resulting in the generation of C3b. Most of the C3b was subsequently degraded to iC3b
(represented by a68 and a43), C3c (represented by a43) and C3dg (not seen in this blot). The a68 fragment of iC3b (the concave band just below
the /3 chain) was distorted by the large amount of albumin in the plasma; Lane d, 60 l of concentrated eluate from plasma treated cuprophan
membrane. Some unactivated C3 was present. Most of the C3-related peptides, however, were in the form of activation product (C3b) or
degradation fragments (iC3b and C3c). B. Immunoblot using anti-C3d. The same duprophan eluate as described in panel A was analyzed using a
polyclonal anti-C3d as the primary antibody. Lane a, I g of C3 showing the a chain. Lane b, I zg of C3 that had been incubated with CVFBb
showing both C3a and C3ba. Lane c, 2.5 1.d of plasma that had been incubated with CVF. Most of the C3 were in the form of degradation fragments.
Lane d, 30 d of concentrated eluate from plasma treated cuprophan membrane. C3bcs, a68 of iC3b and C3dg (Mr 41 kDa) are conspicuous. All
these three fragments contain the C3d domain that is recognized by the anti-C3d antibody. C. Immunoblot using anti-IgG. Cuprophan eluate was
analyzed using the F(ab)'2 fragment of a polyclonal anti-IgG as the primary antibody. Lane a, 3 sg of human IgG. Lane b, 0.5 tl of normal human
serum. Lane c, 30 sl of concentrated eluate from plasma-treated cuprophan membrane showing the heavy (H) and light (L) chain of IgG. Lane
d, 3 zg of human serum albumin.
Effect of inhibition of complement activation on neutrophil neutrophils express receptors for some of these peptides [17]
adherence suggested that neutrophil binding to the plasma treated mem-
branes might be dependent upon complement activation. To
The presence of activation and degradation products of C3 on test this hypothesis, cuprophan membranes were incubated for
cuprophan membranes (Fig. IA and IB) and the fact that two hours with radiolabeled neutrophils in buffer, in NHP, in
a'
.4.
S V.
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bated with NHP. Next, the membranes were washed and
incubated with incremental concentrations of the F(ab)'2 frag-
ment of polyclonal anti-C3. After washing, the treated mem-
branes were incubated with radiolabeled neutrophils, and cell
binding was subsequently quantitated. Neutrophil adherence
was inhibited in a dose-dependent fashion by anti-C3 (Fig. 6A).
When sufficient amount of antibody was used (700 gIml), cell
binding was reduced to a value equivalent to that observed for
binding to membranes that had not been exposed to plasma.
These experiments demonstrate that specific binding of neutro-
phils to plasma treated cuprophan membrane is mediated by
C3-related peptides.
Neutrophils also express receptors for the Fc portion of IgG
(FcRy) [18]. Immunoblotting of eluates from plasma treated
cuprophan membranes using anti-IgG as primary antibody
demonstrated the presence of IgG (Fig. 1C). To determine if
any of the binding of neutrophils to cuprophan membrane is
mediated through receptor-ligand interactions involving FcRy
and membrane bound IgG, plasma treated cuprophan mem-
branes were incubated with incremental concentrations of the
F(ab)'2 fragment of polyclonal anti-IgG, and neutrophil binding
was subsequently quantified. In contrast to anti-C3, anti-IgG
had no effect on cell binding (Fig. 6B).
Effect of anti-CRJ anti-CR3 on neutrophil adherence to
cuprophan membrane
Fig. 2. Identification of cells adherent to cuprophan membrane after
exposure to whole blood. A. Giemsa-Wright stain, Cuprophan mem-
brane discs were incubated with heparinized whole blood, After stain-
ing with Giemsa-Wright reagent, the membrane was examined by light
microscopy at lOOx magnification. Neutrophils were the predominant
adherent cell type. A mononuclear cell can also be seen in the middle of
this field. Erythrocytes were practically absent, indicating that cell
binding is selective. B. Nonspecific esterase stain. Nonspecific esterase
stain identifies 3.7% of the adherent cells to be monocytes.
NHP containing EDTA, or in heat-inactivated NHP. Heating
plasma to 56°C for 30 minutes or treating plasma with EDTA
reduced binding to a level equivalent to that observed when
buffer was substituted for plasma (Fig. 5). EDTA could affect
neutrophil binding in two ways. First, chelation of divalent
cations inhibits complement activation. Second, binding of CR3
is also divalent cation dependent [7]. While the experiments
using EDTA do not distinguish between these two mechanisms
of inhibition, the observation that binding is also dependent
upon heat labile factors is consistent with the hypothesis that
neutrophil adhesion to cuprophan membrane requires comple-
ment activation.
Effect of anti-C3 and anti-IgG on neutrophil adherence to
cuprophan membrane
To determine directly if membrane associated C3 fragments
mediate neutrophil binding, cuprophan membranes were incu-
To identify the specific receptors that mediate neutrophil
binding to cuprophan membrane, radiolabeled neutrophils were
incubated with either monoclonal anti-CR 1 or monoclonal
anti-CR3. The cells were then incubated with plasma treated
cuprophan membranes and binding was subsequently quanti-
tated. Anti-CR 1 failed to inhibit neutrophil binding to a statis-
tically significant degree. At 100 g/ml, anti-CR1 decreased
neutrophil binding by 35% (P = 0.053 vs. pretreatment with
PBS; Fig. 7). In contrast, anti-CR3 inhibited binding in a
concentration dependent fashion with a plateau phase at 25 to
50 tg/ml (not shown) when inhibition reached approximately
60% (P < 0.001 vs. pretreatment with PBS; Fig. 7). When
neutrophils were pretreated with both anti-CR 1 (50 jg/ml) and
anti-CR3 (50 gIml), almost complete inhibition of cell binding
was achieved (Fig. 7).
To determine if bioactive peptides in the fluid phase that are
generated during complement activation (for example, CSa)
affect the capacity of anti-CR3 to inhibit cell binding, isolated
neutrophils were incubated with 50 g/ml of anti-CR1, anti-
CR3, a combination of anti-CR1 and anti-CR3, or nonimmune
IgG. Without washing, the cells were incubated with NHP and
a piece of cuprophan membrane, and binding was subsequently
quantified. Anti-CR3 alone or anti-CR3 combined with anti-CR 1
reduced the binding to a level equivalent to the binding of cells
to membranes in the absence of plasma (Fig. 8). Anti-CR 1 alone
was totally ineffective. These studies demonstrate that neutro-
phil binding to cuprophan membranes in the presence of plasma
is mediated predominately by CR3.
Discussion
Cellulosic hemodialysis membranes induce complement acti-
vation via the APC [1—3, 5, 6]. We have previously demon-
strated the presence of C3 activation and degradation fragments
L\ i\Lza\ -t
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Fig. 3. Scanning EM of neutrophils adherent to cuprophan membrane. A and B. Adherence in the presence of plasma. A piece of cuprophan
membrane that had been incubated with heparinized whole blood for two hours was washed, treated with Karnovsky's fixative and examined by
scanning EM at 2 x io (panel A) or I x lO (panel B) magnification. All the adherent cells displayed extensive lamellipod and retraction fiber
formation towards the cuprophan membrane. The cell left from the center in panel A also showed two elongated retraction fibers which are
typically seen when neutrophils migrate in response to chemotactic stimulus. C. Adherence in the absence of plasma. Neutrophils isolated with
the Ficoll-Paque procedure were incubated with a piece of cuprophan membrane in the presence of HBSS/A. Magnification = 1 x lOg. In the
absence of plasma, few cells adhered to the membrane surface. Those which adhered retained largely their spheroidal appearance that is
characteristic of unactivated peripheral neutrophils. D. Unactivated neutrophil. Neutrophils isolated with the Ficoll-Paque procedure were treated
with Karnovsky's fixative and examined by scanning EM at 1 x lO magnification.
on cuprophan and cellulose acetate membrane surfaces at the
end of four hours of clinical dialysis [5]. The present studies
further identified C3b, iC3b, C3c, and C3dg as the C3 fragments
that were deposited Onto the membranes after incubation of
cuprophan membranes with plasma for two hours (Fig. 1A and
1B). The presence of these C3 fragments on dialysis membranes
suggests that they may bind to surface C3 receptors on periph-
eral neutrophils and elicit cellular responses.
We found that exposure of cuprophan membranes to whole
blood resulted in the adhesion of predominately neutrophils to
the membranes (Fig. 2A). Identification of the adherent mono-
nuclear cells by the monocyte specific surface marker, CD14
antigen, was unsuccessful because the outlines of the appar-
ently positive cells appeared indistinct after staining of the
blood treated membranes with a fluorescein-labeled anti-CD14
(not shown). In contrast, staining using a-naphthyl acetate for
esterase provides clear images of the monocytes (Fig. 2B). By
this procedure, only 3.7% of all the cells adherent to the
cuprophan membrane surface were found to be monocytes.
The relatively small number of monocytes that were present
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Fig. 4. Time dependence of radiolabeled neutrophil adherence to
cuprophan membrane. Cuprophan membranes were incubated with 0.5
ml of HBSS/A containing 2.8 >< 106 radiolabeled neutrophils and 0.5 ml
of NHP. At timed intervals, the membranes were washed and the
number of adherent cells was determined. The data points represent the
mean SEM (N = 9). Neutrophil adherence increased in a linear fashion
over two hours, after which a gradual plateau phase was observed.
6
Fig. S. Effect of inhibition of complement activation on neutrophil
adhesion to cuprophan membrane. Radiolabeled neutrophils were
incubated with cuprophan membranes in the presence of buffer, NHP,
heat inactivated plasma (HI-NHP) or plasma chelated with EDTA
(EDTA-NHP). The bars depict the mean SEM (N = 4). Inhibition of
complement activation by heat treatment or by chelating divalent
cations inhibited neutrophil binding.
on the cuprophan membrane may appear to be inconsistent with
the well described adhesive property of monocytes. It should,
however, be noted that, in contrast to pertri dishes to which
monocytes are known to attach, cuprophan membranes in the
present study were coated with C3 fragments that are capable of
interacting with specific receptors on leukocyte surfaces. Both
peripheral neutrophils and monocytes possess surface C3 re-
ceptors [17] which could potentially promote their binding to
the cuprophan membranes. Theoretically, the relative number
of neutrophils and monocytes that may adhere to the mem-
branes would depend on the relative affinities of the ligands
Anti-IgG, 12g/mI
Fig. 6. Inhibition of neutrophil adherence to plasma treated cu-
prophan membrane by anti-C3. A. Effect of anti-C3. Cuprophan mem-
branes were incubated with NHP or with HBSS/A (buffer) and washed.
Next, the membranes were incubated with either PBS or PBS contain-
ing incremental concentrations of the F(ab)'2 fragment of polyclonal
anti-C3. After washing, radiolabeled neutrophils were added and cell
binding was subsequently quantified. The bars depict mean SEM (N =
4). When sufficient antibody was added, neutrophil binding to plasma
treated membranes (solid bars) was reduced to a value equivalent to (P
> 0.05) that observed for buffer treated membranes (open bar). B.
Effect of anti-lgG. These experiments were conducted as described in
the legend to panel A with the exception that the plasma treated
cuprophan membranes were incubated with incremental concentrations
of the F(ab)'2 fragment of polyclonal anti-IgG. The bars depict the mean
5EM (N = 4). Anti-IgG had no effect on neutrophil binding (solid bars)
(P > 0.05 vs. no anti-LgG), in contrast to 700 gIml of anti-C3 (open
bar).
(membrane-associated C3 fragments) for the cell surface recep-
tors as well as the relative number of each type of cells that are
available. The binding affinities for these ligand-receptor inter-
actions under the present experimental conditions have not
been determined. However, neutrophils are far more abundant
than monocytes are in the peripheral blood, which may partly
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Plasma Buffer
Fig. 7. Effect of anti-CRI and anti-CR3 on neutrophil adherence to
plasma treated cuprophan membranes. Radiolabeled neutrophils were
incubated with PBS or with PBS containing 50 tg/ml of anti-CR!,
anti-CR3, or both. Next, the cells were incubated with cuprophan
membranes that had been exposed to either NHP or HBSS/A (buffer).
After washing, neutrophil adherence was determined. The bars depict
the mean SaM (N = 10). Incubation with anti-CR! reduced the
binding of neutrophils to NHP treated membranes, but only to a value
that is marginally different from that observed with cells incubated with
PBS (P = 0.053). In contrast, anti-CR3 decreased the binding by 61% (P
<0.001 vs. PBS). When cells were pretreated with both anti-CR! and
anti-CR3, the binding decreased further to a value that was equivalent
to (P > 0.05) the binding of cells to buffer treated membranes (open
bar).
explain the predominance of neutrophils on the membrane
surface when cuprophan membrane was exposed to whole
blood (Fig. 2A).
Leukocyte adherence to clinically used dialyzer membranes
has been previously reported. Polymorphonuclear cells were
the predominant cell type on cuprophan coils [20]. Debrand-
Passard and colleagues recently reported the deposition of large
numbers of leukocytes and platelets on cuprophan hollow fiber
membrane after clinical use [211. The specific types of leuko-
cytes were not identified, nor were the mechanisms of adher-
ence of those cells to the membrane. Of interest was the smaller
number of cells that were adherent to cellulose acetate or
Hemophan membranes, surfaces that have been reported to
induce less complement activation compared to cuprophan [22,
23], Whether these membranes also bind neutrophils by the
same mechanism as cuprophan does remain to be investigated.
Significant increases in plasma levels of cytokines have been
demonstrated during hemodialysis [24—261. Bacterial products
in the dialysate have been implicated in the stimulation of
cytokine production by monocytes in the blood compartment
[25]. The mechanisms by which these stimulants and cells come
into contact with each other across the dialysis membrane
barrier are unclear. In view of the scarcity of monocytes that
are found on the cuprophan membrane surface, as demon-
strated in the present study, it seems unlikely that adherence of
monocytes is a prerequisite for the stimulation of these cells in
the hemodialysis circuit. More likely, small bacterial fragments
Anti- Anti- Anti- NI
CR1 CR3 CR1 + IgG
anti-
CR3
Plasma Buffer
Fig. 8. Effect of anti-CRJ and anti-CR3 on neutrophil binding to
cuprophan membrane when cells were incubated with NHP. Radiola-
beled neutrophils were incubated with 50 gJml of anti-CR!, anti-CR3,
both anti-CR I and anti-CR3, or nonimmune lgG. Without washing, the
cells were incubated with cuprophan membranes in the presence of
NHP. After washing, the cells adherent to the membranes were
quantified. The bars depict the mean SaM (N = 10). Pretreatment of
neutrophils with anti-CR! resulted in the same degree of binding (P>
0.05) as pretreatment with nonimmune IgG (NI IgG). In contrast,
pretreatment with either anti-CR3 or the combination of anti-CR! and
anti-CR3 completely inhibited the binding (P > 0.05 vs. binding to
membranes incubated with neutrophils in the presence of HBSS/A
buffer).
actually traverse the dialysis membrane and are therefore
capable of stimulating the monocytes in the circulating blood.
In accordance with this hypothesis is the recent demonstration
of passage of bioactive endotoxins through certain hemodialysis
membranes in vitro [27]. In addition, anaphylatoxins that are
generated as a result of APC activation by the cuprophan
membrane may potentiate the production of cytokines by
monocytes [28]. Whether activation of significant numbers of
adherent monocytes occurs at the interface between blood and
other types of dialysis membranes (for example, those made
from synthetic polymers) is unclear.
Neutrophils that adhered to cuprophan membrane in the
presence of plasma underwent profound morphological changes
(Fig. 3A and 3B). They displayed extensive lamellipod and
retraction fiber formation. Lamellipods consist of a thin layer of
cytoplasm devoid of granules and mitochondria and are usually
formed by rearrangement of the cytoplasm when neutrophils
are migrating in response to chemotactic stimuli [29]. The
formation of these cytoplasmic projections greatly increases the
cell surface area and facilitates the attachment of the cell to the
dialysis membrane.
Neutrophil binding to cuprophan membrane was greatly
enhanced by the presence of plasma (Fig. 5) but was largely
abolished by the addition of EDTA or by preheating of the
plasma at 56°C. Both of these maneuvers prevent complement
activation via the classical and alternative pathway. In addition,
chelation of cations inhibits the contraction of microfilaments
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Fig. 9. Schematic presentation of the roles of
complement and complement receptors in
mediating neutrophil adherence to cuprophan
membranes. Contact of NHP with cuprophan
membrane leads to activation of the APC with
the subsequent deposition of C3b onto the
membrane surface. C3b can participate in the
formation of the APC C3 convertase and C5
convertase. Membrane associated C3b is
degraded into iC3b and C3dg by complement
regulatory proteins present in the plasma.
Membrane bound iC3b interacts with CR3 on
the neutrophil surface, thereby promoting
adherence of the cells to the dialysis
membrane. Hypothetically, the C5a that is
generated as a result of C5 activation may
stimulate the neutrophils to upregulate CR3
and enhance adherence. The interaction
between cuprophan membrane bound C3b and
neutrophil surface CR1 appears to be
relatively weak, but may potentiate the effect
of CR3 in promoting cell adhesion under
certain conditions. Neutrophils also have
gG receptors (CR4 and FcRy) for other proteins,
but they do not appear to contribute
significantly to the adherence of the cells to
cuprophan membrane.
and therefore movement of neutrophils [30] as well as the
binding of ligands to the cell surface adhesive molecule, CR3
[7]. These observations are therefore compatible with, but not
indicative of, the role of complement in mediating the cell
binding.
Inhibition studies using anti-C3, however, clearly showed
that C3-related peptides are crucial in mediating the enhanced
binding in the presence of plasma (Fig. 6A). Despite the
presence of FcRy on neutrophils [17] and the presence of IgG
on the plasma treated membrane surface in the present study
(Fig. 1C), IgG does not appear to play a significant role in
neutrophil adherence to cuprophan membrane (Fig. 6B). Con-
ceivably, IgG bound to the dialysis membrane do not interact
with FcRy because of their particular subtype or form (mono-
mer vs. aggregate) or orientation in which they exist. Alterna-
tively, binding of IgG to dialysis membrane may induce changes
in the configuration of the molecules such that their binding
characteristics are altered.
The complement receptors on the neutrophil surface that
mediate the binding were investigated using specific monoclo-
nal antibodies. Three different receptors (CR1, CR3, and CR4)
on neutrophil surface are known to interact with C3 activation
and degradation fragments. The primary ligands for CR1, CR3,
and CR4 are C3b, iC3b, and C3dg, respectively [17]. Anti-CR3
inhibited —60% of the neutrophil binding to plasma-treated
cuprophan membranes (Fig. 7). Anti-CR! alone decreased cell
adherence by 35% but this decrease was only of marginal
statistical significance. When CR! was added to anti-CR3,
however, complete inhibition of binding was observed. These
observations suggest that the effects of CR! and CR3 might be
synergistic or additive under these particular experimental
conditions. CR3 (also known as Mo! or Mac-!) and two other
proteins, LFA-l and CR4 (p150,95), belong to the integrin
supergene family of receptors [31]. Each of these three proteins
consists of a distinct a chain but they share a common 13chain.
The anti-CR3 (60.1) used in the present studies is directed
against the a chain of CR3 and is therefore specific for this
receptor. Inasmuch as anti-CR3, in conjunction with anti-CR1,
completely inhibited the cell binding (Fig. 7), these observa-
tions suggest that CR4 did not play a significant role in the
adhesion of neutrophils to cuprophan membrane.
It should be noted that, although the anti-CR3 antibody (60.1)
used in the present study is specific for CR3, it is not specific for
the iC3b binding portion of the molecule [32]. CR3 has been
shown to promote cell adhesion to surfaces in the absence of
complement. Therefore, the observation that this antibody
inhibited cell adherence does not, by itself, indicate that CR3
promoted cell adherence to cuprophan membrane by binding to
iC3b. However, we showed that cell adherence could also be
completely inhibited by blocking cuprophan membrane surface-
associated C3 fragments with anti-C3 (Fig. 6A). Taken together,
these two observations strongly suggest that cell adherence to
plasma-treated cuprophan membrane was primarily mediated
by interactions between CR3 and iC3b (Fig. 9).
Even the role of CR! appeared to be trivial when the cells
were incubated with cuprophan membrane in the presence of
plasma. Anti-CR I was totally ineffective under these conditions
(Fig. 8). In contrast, anti-CR3 alone almost completely inhibited
the binding; addition of anti-CR 1 to anti-CR3 produced similar
results. The reasons for the predominance of the CR3 effect
under these conditions (Fig. 8) compared to those in which
neutrophils were incubated with membrane pretreated with
plasma (Fig. 7) are unclear. Conceivably, it is related to the
upregulation of neutrophil CR3 that has been observed when
C3 * C3b -* iC3b —* C3dg
Cuprophan membrane
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neutrophils are exposed to C5a or during clinical hemodialysis
using cuprophan membrane [33].
Under appropriate conditions, binding of particles opsonized
with iC3b to CR3 on neutrophils results in respiratory burst and
ingestion of the particle [17]. Conceivably, interactions between
neutrophil CR3 and iC3b bound to cuprophan membrane sur-
face may produce a pronounced state of 'frustrated phagocy-
tosis" [34] that would also culminate in respiratory burst and
degranulation by the cells. Exposure of neutrophils to cu-
prophan membrane in the presence of plasma has been shown
to stimulate production of oxygen radicals [351 and release of
intragranular proteolytic enzymes [36]. Whether these pro-
cesses are induced by stimulation of CR3 is currently under
investigation. Previous publications have emphasized the im-
portance of fluid phase C5a in mediating dialysis membrane
bioincompatibility events. The present study underlies the
potential importance of C3 activation products, particularly
those that are bound to hemodialysis membranes.
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